Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A02 DRUGS FOR ACID RELATED DISORDERS
A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
A02BD Combinations for eradication of Helicobacter pylori
A02BD07 Lansoprazole, amoxicillin and clarithromycin
D08774 Amoxicillin hydrate, clarithromycin and lansoprazole <US>
J ANTIINFECTIVES FOR SYSTEMIC USE
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J01R COMBINATIONS OF ANTIBACTERIALS
J01RA Combinations of antibacterials
J01RA01 Penicillins, combinations with other antibacterials
D08774 Amoxicillin hydrate, clarithromycin and lansoprazole <US>
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG01639 CYP2C19 substrate
D08774 Amoxicillin hydrate, clarithromycin and lansoprazole
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D08774 Amoxicillin hydrate, clarithromycin and lansoprazole
Metabolizing enzyme inhibitor
DG02852 CYP3A/CYP3A4 inhibitor
DG01522 CYP3A4 inhibitor
D08774 Amoxicillin hydrate, clarithromycin and lansoprazole
Transporter inhibitor
DG01622 ABCB1 inhibitor
D08774 Amoxicillin hydrate, clarithromycin and lansoprazole
Antimicrobials [BR:br08307]
Antibacterials
Cell wall biosynthesis inhibitor, beta-lactam
Combination for eradication of H. pylori
D08774 Amoxicillin hydrate, clarithromycin and lansoprazole <US>
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D08774
Drug transporters
D08774